Switzerland / South Africa / Zimbabwe / Thailand / United States / United Kingdom / /
Currency
USD / / /
Event
FDA Phase / /
Facility
UCLA AIDS Institute / / /
IndustryTerm
sensitivity analysis tool / predictive tools / well-developed health infrastructure / web version / /
MarketIndex
Next 150 / /
MedicalCondition
South Africa epidemic / HIV epidemics / epidemic control agents / HIV / smallpox / epidemic / measles / Rabies / natural infection / tetanus / SHIV infection / HIV epidemic / natural HIV infection / HIV infections / epidemic severity / infectious pathogens / South African HIV epidemic / epidemic switches / DNA vaccines encoding influenza / infections / Influenza / hence epidemic severity / HIV infection / genital ulcerative diseases / epidemic dynamics / sexual transmitted infections / Disease / South African epidemic / Ebola / secondary infections / Venezuelan Equine Encephalitis virus / poliomyelitis / viremia / accurately model current epidemic / epidemic control strategies / superinfection / viral disease / Vaccinia viruses / AIDS / HIV epidemic switches / infectious diseases / B epidemic / infection / South Africa HIV epidemic / epidemic level / Infectious Disorders / acute infection / HIV disease / Venezuelan Equine Encephalitis / /
MedicalTreatment
immunization / antiretroviral therapy / mass vaccination / vaccination / antiretroviral drug treatment / vaccinations / /
Organization
UCLA / UCLA / Los Angeles / World Health Organization / Biomathematics and UCLA AIDS Institute / UCLA AIDS Institute / Department of Biomathematics / World Bank / David Geffen School of Medicine / / /
Current Drug Targets – Infectious Disorders 2005, 5, [removed]Predicting the Potential Public Health Impact of Disease-Modifying HIV Vaccines in South Africa: The Problem of Subtypes